The financials
Alvotech by the numbers
Alvotech (ALVO) reported revenue of $280M in H2 2025 (quarter ended December 31, 2025), up 294% from the same quarter a year earlier. That came with a gross margin of 66% and net loss of $114M. For the full year FY2025, revenue was $586M (+20% year on year) and net income $28M.
| Income statement | H2 2025 | H2 2023 | Change |
|---|---|---|---|
| Revenue | $280M | $71M | +294% |
| Gross profit | $184M | −$22M | to a profit |
| Operating income | $50M | −$166M | to a profit |
| Net income | −$114M | −$465M | n/a |
| Diluted EPS | −$0.39 | −$2.04 | n/a |
Drug Manufacturers - Specialty & Generic
Ranks #27 of 28 by Smart Score